Providence Swedish Cancer Institute

The trials here

What the 8 trials at this site are about, from their registry records.

Conditions

• Ovarian cancer4 trials
• Colorectal cancer2 trials
• Gastric and oesophageal cancer2 trials
• Acute lymphoblastic leukaemia1 trial
• Acute myeloid leukaemia1 trial
• Bladder cancer1 trial
• Childhood cancers1 trial
• Chronic lymphocytic leukaemia1 trial
• Chronic myeloid leukaemia1 trial
• Kidney cancer1 trial
• Lung cancer1 trial
• Melanoma1 trial
• and 5 more

Phase

• Phase 33 trials
• Phase 21 trial

Status

• Recruiting8 trials

Lead sponsor

• Alliance for Clinical Trials in Oncology5 trials
• NRG Oncology3 trials

Running trials

• Recruiting

  Family Communications After Genetic Testing

  NCT07143487· Alliance for Clinical Trials in Oncology· Source

  Contact: Alison K. Conlin (principal investigator)

• Recruiting

  Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

  NCT06580314· Phase 3· NRG Oncology· Source

  Contact: Dan S. Zuckerman (principal investigator)

• Recruiting

  Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  NCT05879926· Phase 3· NRG Oncology· Source

  Contact: Charles W. Drescher (principal investigator)

• Recruiting

  mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

  NCT05677490· Phase 3· Alliance for Clinical Trials in Oncology· Source

  Contact: Alison K. Conlin (principal investigator)

• Recruiting

  Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  NCT05334069· Alliance for Clinical Trials in Oncology· Source

  Contact: Alison K. Conlin (principal investigator)

• Recruiting

  A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

  NCT04251052· NRG Oncology· Source

  Contact: Charles W. Drescher (principal investigator)

• Recruiting

  Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects

  NCT04242095· Alliance for Clinical Trials in Oncology· Source

  Contact: Alison K. Conlin (principal investigator)

• Recruiting

  Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

  NCT02523014· Phase 2· Alliance for Clinical Trials in Oncology· Source

  Contact: Alison K. Conlin (principal investigator)

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Ovarian cancer4 recruiting
• Colorectal cancer2 recruiting
• Gastric and oesophageal cancer2 recruiting
• Acute lymphoblastic leukaemia1 recruiting
• Acute myeloid leukaemia1 recruiting
• Bladder cancer1 recruiting
• Childhood cancers1 recruiting
• Chronic lymphocytic leukaemia1 recruiting
• Chronic myeloid leukaemia1 recruiting
• Kidney cancer1 recruiting
• Lung cancer1 recruiting
• Melanoma1 recruiting
• Meningioma1 recruiting
• Metastatic breast cancer1 recruiting
• Multiple myeloma1 recruiting
• Pancreatic cancer1 recruiting
• Prostate cancer1 recruiting